Impact of the Opioid Safety Initiative on opioid-related prescribing in veterans

Pain

Volumn 158, Issue 5, 2017, Pages 833-839

  Lin, Lewei A ^a   Bohnert, Amy S B ^a,b   Kerns, Robert D ^c   Clay, Michael A ^d   Ganoczy, Dara ^b   Ilgen, Mark A ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

^c YALE UNIVERSITY   (United States)

^d UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Benzodiazepine; Intervention; Opioid; Veteran

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BUTORPHANOL; CODEINE; DEXTROPROPOXYPHENE; FENTANYL; HYDROCODONE; HYDROMORPHONE; LEVORPHANOL; METHADONE; MORPHINE; NALBUPHINE; OPIATE; OXYCODONE; OXYMORPHONE; PENTAZOCINE; PETHIDINE; TAPENTADOL; NARCOTIC ANALGESIC AGENT; PRESCRIPTION DRUG; ALPRAZOLAM; CHLORDIAZEPOXIDE; CLONAZEPAM; DIAZEPAM; ESTAZOLAM; FLURAZEPAM; LORAZEPAM; OXAZEPAM; QUAZEPAM; TEMAZEPAM; TRIAZOLAM;

ADVERSE OUTCOME; ARTICLE; DOSE CALCULATION; DRUG MEGADOSE; DRUG SAFETY; HEALTH CARE MANAGEMENT; HUMAN; OPIOID SAFETY INITIATIVE; OUTCOME ASSESSMENT; OUTPATIENT; PAIN; PATIENT SAFETY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RISK REDUCTION; TIME SERIES ANALYSIS; VETERAN; CHRONIC PAIN; FEMALE; GOVERNMENT; MALE; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA; SUBSTANCE-RELATED DISORDERS; UNITED STATES; VETERANS HEALTH; ASSESSMENT OF HUMANS; CONTROLLED STUDY; MAJOR CLINICAL STUDY; SENSITIVITY ANALYSIS;

ANALGESICS, OPIOID; BENZODIAZEPINES; CHRONIC PAIN; FEMALE; HOSPITALS, VETERANS; HUMANS; MALE; PRESCRIPTION DRUGS; RETROSPECTIVE STUDIES; SUBSTANCE-RELATED DISORDERS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS; VETERANS; VETERANS HEALTH;

EID: 85018446163     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1097/j.pain.0000000000000837     Document Type: Article

References (32)

1. Bohnert AS, Ilgen MA, Galea S, McCarthy JF, Blow FC. Accidental poisoning mortality among patients in the department of veterans affairs health system. Med Care 2011;49:393-6.
2. Bohnert AS, Ilgen MA, Trafton JA, Kerns RD, Eisenberg A, Ganoczy D, Blow FC. Trends and regional variation in opioid overdose mortality among Veterans Health Administration patients, fiscal year 2001 to 2009. Clin J Pain 2014;30:605-12.
3. Bohnert AS, Valenstein M, Bair MJ, Ganoczy D, McCarthy JF, Ilgen MA, Blow FC. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA 2011;305:1315-21.
4. Buscaglia AC, Paik MC, Lewis E, Trafton JA. Baseline variation in use of VA/DOD clinical practice guideline recommended opioid prescribing practices across VA health care systems. Clin J Pain 2015;31:803-12.
5. Compton WM, Boyle M, Wargo E. Prescription opioid abuse: problems and responses. Prev Med 2015;80:5-9.
6. Compton WM, Volkow ND. Major increases in opioid analgesic abuse in the United States: concerns and strategies. Drug Alcohol Depend 2006; 81:103-7.
7. Dasgupta N, Funk MJ, Proescholdbell S, Hirsch A, Ribisl KM, Marshall S. Cohort study of the impact of high-dose opioid analgesics on overdose mortality. Pain Med 2015;17:85-98.
8. Dowell D, Haegerich TM, Chou R. CDC guideline for prescribing opioids for chronic Pain-United States, 2016. JAMA 2016;315:1624-45.
9. Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, Weisner CM, Silverberg MJ, Campbell CI, Psaty BM, Von Korff M. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med 2010;152:85-92.
10. Garcia MM, Angelini MC, Thomas T, Lenz K, Jeffrey P. Implementation of an opioid management initiative by a state Medicaid program. J Manag Care Spec Pharm 2014;20:447-54.
11. Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med 2011;171:686-91.
12. Goodman F. Helping to achieve safe medication use: potential doserelated risk of opioid deaths in veterans. Medication safety in seconds: a monthly publication from VA MedSAFE. 2011;1:1-2.
13. Goodman A, Kivlahan D, Liberto J, McNicholas L, Oslin D, Saxon A, Trafton J. Buprenorphine/Naloxone and Buprenorphine for opioid dependence-criteria for use in for office based opioid treatment settings: VHA Pharmacy Benefits Management, 2014. http://www.pbm.va. gov/clinicalguidance/criteriaforuse/Buprenorphine-for-Opioid-Dependence- or-Opioid-Use-Disorder-Criteria-for-Use.pdf. Accessed 9 September 2016.
14. Herzig SJ, Rothberg MB, Cheung M, Ngo LH, Marcantonio ER. Opioid utilization and opioid-related adverse events in nonsurgical patients in US hospitals. J Hosp Med 2014;9:73-81.
15. Ivers N, Jamtvedt G, Flottorp S, Young JM, Odgaard-Jensen J, French SD, O'Brien MA, Johansen M, Grimshaw J, Oxman AD. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev 2012;6:CD000259.
16. Kim H, Hartung DM, Jacob RL, McCarty D, McConnell KJ. The concentration of opioid prescriptions by providers and among patients in the Oregon medicaid program. Psychiatr Serv 2016;67:397-404.
17. Kryskalla J, Kern S, Gray D, Hauser P. Using dashboard technology to monitor overdose risk: federal practitioner. Fed Pract 2014;31:8-14.
18. Larochelle MR, Zhang F, Ross-Degnan D, Wharam JF. Rates of opioid dispensing and overdose after introduction of abuse-deterrent extendedrelease oxycodone and withdrawal of propoxyphene. JAMA Intern Med 2015;175:978-87.
19. Lasser KE, Shanahan C, Parker V, Beers D, Xuan Z, Heymann O, Lange A, Liebschutz JM. A multicomponent intervention to improve primary care provider adherence to chronic opioid therapy guidelines and reduce opioid misuse: a cluster randomized controlled trial protocol. J Subst Abuse Treat 2016;60:101-9.
20. Liu Y, Logan JE, Paulozzi LJ, Zhang K, Jones CM. Potential misuse and inappropriate prescription practices involving opioid analgesics. Am J Manag Care 2013;19:648-65.
21. National Center for Injury Prevention and Control. CDC compilation of opioid analgesic formulationswithmorphinemilligram equivalent conversion factors, 2014 Available at: version. https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/Downloads/Opioid-Morphine-EQ-Conversion-Factors-March-2015.pdf. Accessed 7 January 2016.
22. Nuckols TK, Anderson L, Popescu I, Diamant AL, Doyle B, Di Capua P, Chou R. Opioid prescribing: a systematic review and critical appraisal of guidelines for chronic pain. Ann Intern Med 2014;160:38-47.
23. Okie S. A flood of opioids, a rising tide of deaths. N Engl J Med 2010;363: 1981-5.
24. Park TW, Saitz R, Ganoczy D, Ilgen MA, Bohnert AS. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. BMJ 2015; 350:h2698.
25. Rudd RA, Aleshire N, Zibbell JE, Gladden RM; National Center for Injury Prevention and Control, CDC. Increases in drug and opioid overdose deaths-United States, 2000-2014. MMWR Morb Mortal Wkly Rep 2016;64:1378-82.
26. Tamayo-Sarver JH, Dawson NV, Cydulka RK, Wigton RS, Baker DW. Variability in emergency physician decision making about prescribing opioid analgesics. Ann Emerg Med 2004;43:483-93.
27. The Management of Opioid Therapy for Chronic Pain Working Group. VA/DoD clinical practice guideline: management of opioid therapy for chronic pain: Department of Veterans Affairs and Department of Defense, 2010. http://www.va.gov/painmanagement/docs/cpg-opioidtherapy-summary.pdf. Accessed 7 January 2016.
28. U.S. Department of Veteran Affairs. National center for veterans analysis and statistics. number of veteran patients by healthcare priority group: FY2000 to FY2014. Available at: http://www.va.gov/vetdata/Utilization. asp. Accessed July 16, 2016.
29. Von Korff M, Dublin S, Walker RL, Parchman M, Shortreed SM, Hansen RN, Saunders K. The impact of opioid risk reduction initiatives on highdose opioid prescribing for patients on chronic opioid therapy. J Pain 2016;17:101-10.
30. Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther 2002;27:299-309.
31. Westanmo A, Marshall P, Jones E, Burns K, Krebs EE. Opioid dose reduction in a VA health care system-implementation of a primary care population-level initiative. Pain Med 2015;16:1019-26.
32. Zedler B, Xie L, Wang L, Joyce A, Vick C, Kariburyo F, Rajan P, Baser O, Murrelle L. Risk factors for serious prescription opioid-related toxicity or overdose among veterans health administration patients. Pain Med 2014; 15:1911-29.